Development of Artificial Intelligence-based Machine Learning Models for Predicting Survival In Hormone-Receptor-Positive/HER2-Negative Early Breast Cancer undergoing Neoadjuvant Chemotherapy

被引：0
|
作者：
Mastrantoni, Luca
Garufi, Giovanna
Maliziola, Noemi
Di Monte, Elena
Arcuri, Giorgia
Frescura, Valentina
Rotondi, Angelachiara
Giordano, Giulia
Carbognin, Luisa
Fabi, Alessandra
Paris, Ida
Franceschini, Gianluca
Orlandi, Armando
Palazzo, Antonella
Scambia, Giovanni
Tortora, Giampaolo
Bria, Emilio
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO2-01-14
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO2-01-14
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Validation of Magee equation in predicting response to neoadjuvant chemotherapy in breast cancer patients with hormone receptor positive and HER2 negative
    Saigosoom, N.
    O-charoenrat, P.
    Udompunturak, S.
    Sanguanraksa, D.
    BREAST, 2019, 44 : S73 - S73
  • [32] Molecular classification of hormone receptor-positive HER2-negative breast cancer
    Jin, Xi
    Zhou, Yi-Fan
    Ma, Ding
    Zhao, Shen
    Lin, Cai-Jin
    Xiao, Yi
    Fu, Tong
    Liu, Cheng-Lin
    Chen, Yi-Yu
    Xiao, Wen-Xuan
    Liu, Ya-Qing
    Chen, Qing-Wang
    Yu, Ying
    Shi, Le-Ming
    Shi, Jin-Xiu
    Huang, Wei
    Robertson, John F. R.
    Jiang, Yi-Zhou
    Shao, Zhi-Ming
    NATURE GENETICS, 2023, 55 (10) : 1696 - +
  • [33] A prospective, phase II, neoadjuvant clinical study based on chemotherapy sensitivity in hormone receptor-positive, HER2-negative breast cancer: FINEST study
    Chen, Li
    Li, Junjie
    Wang, Zhonghua
    Wu, Wenya
    Li, Huajun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [34] Molecular classification of hormone receptor-positive HER2-negative breast cancer
    Xi Jin
    Yi-Fan Zhou
    Ding Ma
    Shen Zhao
    Cai-Jin Lin
    Yi Xiao
    Tong Fu
    Cheng-Lin Liu
    Yi-Yu Chen
    Wen-Xuan Xiao
    Ya-Qing Liu
    Qing-Wang Chen
    Ying Yu
    Le-Ming Shi
    Jin-Xiu Shi
    Wei Huang
    John F. R. Robertson
    Yi-Zhou Jiang
    Zhi-Ming Shao
    Nature Genetics, 2023, 55 : 1696 - 1708
  • [35] Case Report: Paclitaxel weekly induced Pneumonitis in neoadjuvant Therapy of an early Hormone Receptor-positive/HER2-negative Breast Cancer
    Mergel, F.
    Pfister, K.
    Darkovski, Veta J.
    Fink, A.
    Rack, B.
    PNEUMOLOGIE, 2024, 78 : S75 - S75
  • [36] Do ESR1-related mutations generate neoantigens in hormone-receptor-positive HER2-negative metastatic breast cancer?
    Lopez, M.
    Spehner, L.
    Ramseyer, M.
    Bouard, A.
    Dobi, E.
    Curtit, E.
    Borg, C.
    Mansi, L.
    ANNALS OF ONCOLOGY, 2023, 34 : S382 - S382
  • [37] Budget Impact of the Oncotype DX Breast Recurrence Score® Test in Patients with Early Primary Hormone-Receptor-Positive, HER2-Negative, Node-Positive Breast Cancer in Germany
    Lux, Michael Patrick
    Minartz, Christof
    Mueller-Huesmann, Harald
    Sandor, Marianar Felicia
    Radeck-Knorre, Sabine
    Neubauer, Aljoscha Steffen
    BREAST CARE, 2024, 19 (01) : 27 - 33
  • [38] Clinicopathological factors for predicting tumor response in hormonal positive/HER2-negative breast cancer patients receiving neoadjuvant chemotherapy
    Yincharoen, P.
    Samarnthai, N.
    Korphaisarn, K.
    Imruetaicharoenchoke, W.
    BREAST, 2023, 68 : S57 - S57
  • [39] Untreated hormone receptor positive/HER2-negative metastatic breast cancer survival with front-line chemotherapy and maintenance endocrine therapy
    Sabatier, R.
    Meskine, A.
    Cappiello, M. A.
    Extra, J-M.
    Tarpin, C.
    Rousseau, F.
    Provansal, M.
    Bertucci, F.
    Viens, P.
    Goncalves, A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [40] Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancer
    Loo, Claudette E.
    Rigter, Lisanne S.
    Pengel, Kenneth E.
    Wesseling, Jelle
    Rodenhuis, Sjoerd
    Peeters, Marie-Jeanne T. F. D. Vrancken
    Sikorska, Karolina
    Gilhuijs, Kenneth G. A.
    BREAST CANCER RESEARCH, 2016, 18
12345